Skip to content

Uncategorized: Register™

ArisGlobal’s LifeSphere clinical and regulatory product leader will host a workshop and virtual discussion on TMF health.

NEW ORLEANS, LA – Sondra Pepe, Associate Vice President, Clinical and Regulatory Product Management, ArisGlobal, will provide insights and perspective at the tenth annual TMF Summit, a renowned event for top-tier discussions around eTMF innovations, integrated technology, and inspection readiness.

Pepe will lead a virtual workshop on Monday, October 25th entitled, “Inspection Readiness: TMF Quality Review,” which will hone in on actionable ways clinical teams can improve and innovate document management and other pertinent data.

Later in the week, Pepe will also be the featured expert on “Digital Disruption and TMF Health,” as a part of the Emerging Technology track. This conversation will highlight ways that clinical processes are evolving from start to finish through accurate, scalable, and quick click to configure industry standards like LifeSphere eTMF.

“It’s been a big year in eTMF technology regarding interoperability and automation, and I am honored to share the ways that LifeSphere eTMF is advancing clinical abilities for teams large and small,” shares Pepe. “TMF Summit is such an inspiring event full of knowledge and innovation, and it’s exciting to lead conversations on how technology is ushering in a new frontier for our industry.”

Sondra Pepe leads product management for ArisGlobal’s Clinical and Regulatory solution portfolios. In this role, she is responsible for defining product strategies and roadmaps, and overseeing the growth of the domains. Prior to ArisGlobal, Sondra gained nearly 20 years of experience in eClinical SaaS technology across a variety of companies and products, including leading roles in product management at Veeva and Medidata, working on CTMS, EDC and RTSM product sets.

About ArisGlobal
ArisGlobal transforms the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Their end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep industry expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture. In 2021, Frost & Sullivan recognized ArisGlobal with the Customer Value Leadership Award for Clinical Development and Pharmacovigilance Software.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information
Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global
Media Contact
Erika Thomas
ArisGlobal
[email protected]

ArisGlobal Launches LifeSphere NavaX™   Learn More

Join us at Breakthrough 2024 to explore life sciences transformation through Intelligent Automation

Register Here